相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Brain Atrophy in Natalizumab-treated Patients with Multiple Sclerosis: A 5-year Retrospective Study
Philipp Eisele et al.
JOURNAL OF NEUROIMAGING (2019)
Reduced brain atrophy rates are associated with lower risk of disability progression in patients with relapsing multiple sclerosis treated with cladribine tablets
Nicola De Stefano et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Reduced brain atrophy rates are associated with lower risk of disability progression in patients with relapsing multiple sclerosis treated with cladribine tablets
Nicola De Stefano et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Brain MRI atrophy quantification in MS From methods to clinical application
Maria A. Rocca et al.
NEUROLOGY (2017)
Teriflunomide slows BVL in relapsing MS A reanalysis of the TEMSO MRI data set using SIENA
Ernst-Wilhelm Radue et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2017)
Effect of Fingolimod on Brain Volume Loss in Patients with Multiple Sclerosis
Nicola De Stefano et al.
CNS DRUGS (2017)
Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis
Nicola De Stefano et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
A regional consensus recommendation on brain atrophy as an outcome measure in multiple sclerosis
Raed Alroughani et al.
BMC NEUROLOGY (2016)
Time course of clinical and neuroradiological effects of delayed-release dimethyl fumarate in multiple sclerosis
L. Kappos et al.
EUROPEAN JOURNAL OF NEUROLOGY (2015)
Effects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM study
David H. Miller et al.
NEUROLOGY (2015)
The Effect of Disease Modifying Therapies on Brain Atrophy in Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis
Georgios Tsivgoulis et al.
PLOS ONE (2015)
Treatment Effect on Brain Atrophy Correlates with Treatment Effect on Disability in Multiple Sclerosis
Maria Pia Sormani et al.
ANNALS OF NEUROLOGY (2014)
Effects of delayed-release dimethyl fumarate on MRI measures in the Phase 3 DEFINE study
Douglas L. Arnold et al.
JOURNAL OF NEUROLOGY (2014)
Brain atrophy and disability progression in multiple sclerosis patients: a 10-year follow-up study
Cecilie Jacobsen et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
Correlation between brain volume change and T2 relaxation time induced by dehydration and rehydration: Implications for monitoring atrophy in clinical studies
Kunio Nakamura et al.
NEUROIMAGE-CLINICAL (2014)
Optimizing parameter choice for FSL-Brain Extraction Tool (BET) on 3D T1 images in multiple sclerosis
V. Popescu et al.
NEUROIMAGE (2012)
Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
Robert J. Fox et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
Ralf Gold et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes
N. De Stefano et al.
NEUROLOGY (2010)
Pooled historical MRI data as a basis for research in multiple sclerosis - a statistical evaluation
S. Schach et al.
MULTIPLE SCLEROSIS (2007)
Brain atrophy and cognitive impairment in multiple sclerosis: a review
Michael Lanz et al.
JOURNAL OF NEUROLOGY (2007)
MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS
D. H. Miller et al.
NEUROLOGY (2007)
The measurement and clinical relevance of brain atrophy in multiple sclerosis
RA Bermel et al.
LANCET NEUROLOGY (2006)
Steroids and brain atrophy in multiple sclerosis
R Zivadinov
JOURNAL OF THE NEUROLOGICAL SCIENCES (2005)
Rate of brain atrophy in relapsing MS decreases during treatment with IFNβ-1a
M Hardmeier et al.
NEUROLOGY (2005)
Measurement error of two different techniques for brain atrophy assessment in multiple sclerosis
MP Sormani et al.
NEUROLOGY (2004)
Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance
David H. Miller et al.
BRAIN (2002)
Short-term brain volume change in relapsing-remitting multiple sclerosis - Effect of glatiramer acetate and implications
M Rovaris et al.
BRAIN (2001)
Normalized accurate measurement of longitudinal brain change
SM Smith et al.
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY (2001)
分享论文
